Brazil becomes the first malaria-endemic country to register single-dose tafenoquine for children with relapsing malaria 21 Aug 2023
WHO call for public consultation on preferred product characteristics (PPCs) on tests for risk of P. vivax relapse 10 Aug 2023
Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria 06 Jun 2023
MMV’s film on real-world tafenoquine study wins advocacy award at the 7th annual ISNTD festival 28 Mar 2023
Regional initiatives and evidence-generation efforts to eliminate P. vivax malaria in Latin America 05 Dec 2022
Start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol in Thailand 22 Jul 2022
Highlights from the Partnership for Vivax Elimination (PAVE) Greater Mekong Subregion (GMS) Country Coordinator Experience Exchange 30 Apr 2022
Event Highlights from the 2022 International Conference on Plasmodium vivax Research (ICPvR) 11 Apr 2022
Single-dose Kozenis (tafenoquine) approved for children with Plasmodium vivax malaria by Australian Therapeutic Goods Administration 14 Mar 2022